Stay updated on Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.

Latest updates to the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoved the government funding status notice that was previously shown; the study details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study page details appear unchanged between the two screenshots; no additions or deletions to cohorts, eligibility criteria, or outcomes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedUpdated page to v3.2.0, added government-status notice about potential delays, and removed a resource on Mature T-cell and NK-cell non-Hodgkin lymphoma.SummaryDifference3%

- Check78 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdates the page from Revision: v3.0.1 to Revision: v3.0.2, signaling a new release. The 'Back to Top' link/element has been removed, a minor navigation-quality change.SummaryDifference0.1%

Stay in the know with updates to Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Study AFM13 in R/R CD30+ T-cell Lymphoma Clinical Trial page.